OKYO
OKYO Pharma Ltd ADR
NASDAQ: OKYO · HEALTHCARE · BIOTECHNOLOGY
$1.56
+2.63% today
Updated 2026-04-30
Market cap
$82.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
OKYO Pharma Ltd ADR (OKYO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-2,969.00%
ROA
-104.60%
Debt/equity
-0.05x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-2.97M | — | — | — |
| 2009 | — | $14.33M | — | — | — |
| 2010 | — | $12.67M | — | — | — |
| 2011 | — | $-1.62M | — | — | — |
| 2012 | — | $-4.80M | — | — | — |
| 2013 | — | $-4.84M | — | — | — |
| 2014 | — | $-13.95M | — | — | — |
| 2015 | — | $-8.26M | — | — | — |
| 2016 | — | $-820171.00 | — | — | — |
| 2017 | — | $-241927.00 | — | — | — |
| 2018 | — | $-28.30M | — | — | — |
| 2019 | $0.00 | $-4.89M | — | — | — |
| 2020 | $0.00 | $-1.54M | — | — | — |
| 2021 | $0.00 | $-3.35M | — | — | — |
| 2022 | $0.00 | $-5.43M | — | — | — |
| 2023 | $0.00 | $-13.27M | — | — | — |
| 2024 | $0.00 | $-16.83M | — | — | — |
| 2025 | $0.00 | $-4.71M | — | — | — |